Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
Nature Communications
Hong, Lingzhi L; Aminu, Muhammad M; Li, Shenduo S; Lu, Xuetao X; Petranovic, Milena M; Saad, Maliazurina B MB; Chen, Pingjun P; Qin, Kang K; Varghese, Susan S; Rinsurongkawong, Waree W; Rinsurongkawong, Vadeerat V; Spelman, Amy A; Elamin, Yasir Y YY; Negrao, Marcelo V MV; Skoulidis, Ferdinandos F; Gay, Carl M CM; Cascone, Tina T; Gandhi, Saumil J SJ; Lin, Steven H SH; Lee, Percy P PP; Carter, Brett W BW; Wu, Carol C CC; Antonoff, Mara B MB; Sepesi, Boris B; Lewis, Jeff J; Gibbons, Don L DL; Vaporciyan, Ara A AA; Le, Xiuning X; Jack Lee, J J; Roy-Chowdhuri, Sinchita S; Routbort, Mark J MJ; Gainor, Justin F JF; Heymach, John V JV; Lou, Yanyan Y; Wu, Jia J; Zhang, Jianjun J; Vokes, Natalie I NI
A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases.
Cancers
Tyran, Marguerite M; Carbuccia, Nadine N; Garnier, Séverine S; Guille, Arnaud A; Adelaïde, José J; Finetti, Pascal P; Toulzian, Julien J; Viens, Patrice P; Tallet, Agnès A; Goncalves, Anthony A; Metellus, Philippe P; Birnbaum, Daniel D; Chaffanet, Max M; Bertucci, François F
Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
Oncotarget
Lim, Sun Min SM; Kim, Eun Young EY; Kim, Hye Ryun HR; Ali, Siraj M SM; Greenbowe, Joel R JR; Shim, Hyo Sup HS; Chang, Hyun H; Lim, Seungtaek S; Paik, Soonmyung S; Cho, Byoung Chul BC